Jeonjinbio Co., Ltd. (KOSDAQ:110020)
1,895.00
-98.00 (-4.92%)
At close: May 20, 2026
Jeonjinbio Market Cap
Jeonjinbio has a market cap or net worth of 17.17 billion as of May 20, 2026. Its market cap has decreased by -23.74% in one year.
Market Cap
17.17B
Enterprise Value
10.75B
Revenue
13.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,895.00
Market Cap Chart
Since December 14, 2018, Jeonjinbio's market cap has decreased from 60.35B to 17.17B, a decrease of -71.56%. That is a compound annual growth rate of -15.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 17.17B | -24.80% |
| Dec 30, 2025 | 22.83B | 7.23% |
| Dec 30, 2024 | 21.29B | -64.57% |
| Dec 28, 2023 | 60.09B | 134.91% |
| Dec 29, 2022 | 25.58B | -25.29% |
| Dec 30, 2021 | 34.24B | -48.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pintel | 17.89B |
| PCL, Inc. | 17.87B |
| CUROHOLDINGS | 17.44B |
| BioInfra | 17.41B |
| Nuvotec | 16.93B |
| Samyoung S&C | 16.89B |
| Mirae Asset Vision Special Purpose Acquisition 7 Company | 16.88B |
| KESPION | 16.74B |